TEFM and Congenital myasthenic syndromes: The responsiveness of these patients to salbutamol, a drug commonly used to alleviate symptoms of fatigable muscle weakness in the Congenital Myasthenic Syndromes (primary disorders of the NMJ), suggests an involvement of TEFM in neuromuscular structure or function.